Cite
Organizing Pneumonia after Nivolumab Treatment in a Patient with Pathologically Proven Idiopathic Pulmonary Fibrosis
MLA
Yuji Minegishi, et al. “Organizing Pneumonia after Nivolumab Treatment in a Patient with Pathologically Proven Idiopathic Pulmonary Fibrosis.” Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi, vol. 86, no. 1, Mar. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....799f70363223ad07b6777400724ed6f1&authtype=sso&custid=ns315887.
APA
Yuji Minegishi, Tomomi Kato, Yoshinobu Saito, Kenichiro Atsumi, Masahiro Seike, Akihiko Gemma, Yasuhiro Terasaki, Kaoru Kubota, & Takeru Kashiwada. (2019). Organizing Pneumonia after Nivolumab Treatment in a Patient with Pathologically Proven Idiopathic Pulmonary Fibrosis. Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi, 86(1).
Chicago
Yuji Minegishi, Tomomi Kato, Yoshinobu Saito, Kenichiro Atsumi, Masahiro Seike, Akihiko Gemma, Yasuhiro Terasaki, Kaoru Kubota, and Takeru Kashiwada. 2019. “Organizing Pneumonia after Nivolumab Treatment in a Patient with Pathologically Proven Idiopathic Pulmonary Fibrosis.” Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi 86 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....799f70363223ad07b6777400724ed6f1&authtype=sso&custid=ns315887.